Published:
Locus Pharmaceuticals Announces Focus on Drug Discovery Collaboration Business, Branded as Ansaris
BLUE BELL, Pa. - (BUSINESS WIRE) - Locus Pharmaceuticals, a drug company that has developed its own
internal and partnered pipeline, focusing on oncology, immunology, and
inflammatory targets, today announced that in conjunction with a
transformation to a drug discovery collaboration business model, it has
created a new division, Ansaris, which will include most of its
operations and personnel. Ansaris was formed to leverage the strengths
and fully realize the value of Locus' drug discovery computational
platform and 10 years' experience in integrated drug design, discovery,
and development. Ansaris establishes collaborations and partnerships
with companies seeking innovative solutions to drug design challenges.
"We adopted the name Ansaris to symbolize our differentiated approach to
drug discovery, leveraging our demonstrated expertise in computational
chemistry, medicinal chemistry, and our unique fragment-based drug
discovery technology platform," said Joan Lau, President of Ansaris.
"The strength of the Ansaris discovery process lies not just with the
technology, but also the integrated drug design team approach, uniquely
customized for each project. We have effectively utilized our
capabilities to deliver novel chemotypes for challenging targets for our
internal pipeline, and now we will direct our successful discovery model
toward delivering innovative preclinical candidates for our
collaboration partners."
About Ansaris Technology
Ansaris has developed and successfully applied a novel virtual
fragment-based drug design (FBDD) platform into an integrated system for
drug discovery. Driven by computational protein modeling and FBDD
technology, Ansaris' technology supports rapid discovery of novel
target-selective drug molecules. The technology platform is broadly
applicable to many target classes including, but not limited to,
kinases, proteases, and receptors. Drug design teams comprised of
experienced computational and medicinal chemists utilize the suite of
Ansaris computational tools to enable iterative and efficient transition
of molecular designs from concept to synthesis and optimization.
About Locus
Locus is a privately held drug discovery and development biotechnology
company in Blue Bell, PA that creates novel therapeutics using its
patented drug design technology. It has entered into several drug
discovery collaboration projects with pharmaceutical partners, and built
a pipeline of early drug development assets for cancer and inflammatory
indications.
Locus Pharmaceuticals
Joan M. Lau, PhD, MBA, President
215-358-2001
www.ansarisbio.com
Copyright © 2009, Business Wire, Inc., All rights reserved.
Copyright © 2009, NewsBlaze,
Daily NewsTags: Business wire, Healthcare, pennsylvania, Health, Biotechnology, Pharmaceuticals
Search News
Daily News
